Electra Therapeutics Inc.

Electra Therapeutics filed for a Nasdaq Global Select Market IPO under symbol “ETRA” to fund its immune‑disease drug pipeline. Lead candidate ipsoprubart, a monoclonal antibody for secondary hemophago